In accordance with the Rules and Procedures of the 2010–2015 Council of Experts, the Monographs—Small Molecules 2 Expert Committee has revised the Cilostazol Tablets monograph. The purpose for the revision is to add a Dissolution Test 2 and Dissolution Test 3 for products approved by the Food and Drug Administration.
The Cilostazol Tablets Revision Bulletin supersedes the currently official monograph for Cilostazol Tablets. The Revision Bulletin will be incorporated in USP 34–NF 29.
Should you have any questions, please contact Margareth Marques (301-816-8106 or MRM@usp.org).